Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma

被引：0
作者：
Yuki Nemoto
Hiroki Ishihara
Kazutaka Nakamura
Hidekazu Tachibana
Hironori Fukuda
Kazuhiko Yoshida
Hirohito Kobayashi
Junpei Iizuka
Hiroaki Shimmura
Yasunobu Hashimoto
Kazunari Tanabe
Tsunenori Kondo
Toshio Takagi
机构：
[1] Saiseikai Kawaguchi General Hospital,Department of Urology
[2] Tokyo Women’s Medical University,Department of Urology
[3] Tokyo Women’s Medical University Medical Center East,Department of Urology
[4] Tokiwakai Jyoban Hospital,Department of Urology
[5] Saiseikai Kurihashi Hospital,Department of Urology
来源：
International Urology and Nephrology | 2022年 / 54卷
关键词：
RCC; Aging; Immunotherapy; PD-1, CTLA-4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 54
页数：7
相关论文
共 118 条
  • [1] Maughan BL(2017)Incidence of immune-related adverse events with program death receptor-1- and program death receptor-1 ligand-directed therapies in genitourinary cancers Front Oncol 7 2084-2091
  • [2] Bailey E(2005)Costimulatory molecule B7–H1 in primary and metastatic clear cell renal cell carcinoma Cancer 104 1069-1086
  • [3] Gill DM(2018)Fundamental mechanisms of immune checkpoint blockade therapy Cancer Discov 8 151-156
  • [4] Agarwal N(2019)Updated European association of urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma Eur Urol 76 1277-1290
  • [5] Thompson RH(2018)Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma N Engl J Med 378 1116-1127
  • [6] Gillett MD(2019)Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma N Engl J Med 380 829-841
  • [7] Cheville JC(2021)Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma N Engl J Med 384 1803-1813
  • [8] Lohse CM(2021)Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma N Engl J Med 373 2399-2406
  • [9] Dong H(2015)Nivolumab versus everolimus in advanced renal-cell carcinoma N Engl J Med 68 228-247
  • [10] Webster WS(2020)Cancer prevention and screening for older adults: part 1. Lung, colorectal, bladder, and kidney cancer J Am Geriatr Soc 45 1543-1550
12345678910